US Corporate Board Director Changes SEC Filings — March 23, 2026

23-03-2026

BioAtla, Inc. stockholders overwhelmingly approved the Merger Proposal for a 1-for-50 share consolidation (Merger with wholly-owned subsidiary BA Merger Sub, Inc.) at the reconvened Special Meeting on March 23, 2026, with 49.2 million votes in favor out of 50.7 million shares present (68% quorum). Amid challenges including no bonuses earned for 2025 due to missed financial milestones and no 2026 salary increases, the Compensation Committee approved retention bonuses for CFO Christian Vasquez ($37K Milestone #1, $149K #2) and CMO Eric Sievers ($53K #1, $212K #2), while the Board approved $450K for CEO Jay Short, all contingent on financial/capital milestones by May 31 and/or August 31, 2026.

• ·Retention bonuses on sliding scale: 80-120% of target based on milestone achievement (±20% threshold); no payout if >20% miss.
• ·Milestone #1 payouts by June 30, 2026; Milestone #2 and Short bonus by September 30, 2026; requires employment in good standing.
• ·Merger effective date to be announced at least two business days prior, subject to Nasdaq notice periods.

23-03-2026

Verde Clean Fuels, Inc. appointed George Burdette, its current CFO since October 2024, as new CEO, succeeding Ernie Miller who is stepping down to pursue other opportunities but will remain as a senior advisor. The company engaged Roth Capital Partners as a financial advisor to evaluate strategic alternatives, including potential merger, sale, or other transactions involving its STG+® technology, as part of ongoing restructuring and cost reduction initiatives. While positioned as a step to maximize shareholder value through capital-lite opportunities, the process has no set timetable and no assurance of any transaction.

• ·George Burdette previously served as CFO of Arbor Renewable Gas and Itafos, and head of project finance at First Solar.
• ·No binding agreements entered for strategic alternatives; company does not intend to disclose developments unless required.
• ·Announcement dated March 20, 2026; SEC filing March 23, 2026.

23-03-2026

Cardinal Health appointed Patricia A. Hemingway Hall as Board Chair effective immediately, succeeding Gregory B. Kenny upon his retirement; Kenny had served on the Board since 2007 and as Chairman since 2018. CEO Jason Hollar expressed gratitude for Kenny's leadership during periods of transformation and confidence in Hemingway Hall's continuation of strong governance. The company reaffirmed confidence in its fiscal 2026 outlook ahead of third quarter earnings release on April 30.

• ·Ms. Hemingway Hall served on the Board since 2013 and as Chair of the Governance and Sustainability Committee for nearly seven years.
• ·Former CEO role of Ms. Hemingway Hall: President and Chief Executive Officer of Health Care Service Corporation.
• ·Third quarter fiscal 2026 earnings release scheduled for April 30, 2026.

23-03-2026

Ingredion Incorporated announced the retirement of director Gregory B. Kenny effective March 23, 2026, after serving since 2005, stating it was not due to any disagreement with company operations, policies, or practices. The Board elected Siobhán Talbot, former CEO of Glanbia plc, as an independent director effective April 1, 2026; she will receive standard non-management director compensation including cash and equity retainers.

• ·Gregory B. Kenny informed company of retirement decision on March 20, 2026.
• ·Siobhán Talbot, age 62, served Glanbia plc for 31 years, including as CEO from November 2013 to December 2023.
• ·Talbot serves on CRH plc board and audit committee.
• ·Director compensation details in proxy statement filed April 9, 2025.

23-03-2026

State Street Corporation elected Susan Gordon as an independent director on March 19, 2026, with appointments to the Examining and Audit Committee and the Technology and Operations Committee. She will receive a pro rata share of the 2025-2026 $110,000 annual retainer and $235,000 common stock retainer, based on the NYSE closing price on the election date. There are no related arrangements or understandings, and she will enter into a standard indemnification agreement.

• ·Election disclosed in Form 8-K filed March 23, 2026, referencing Exhibits 10.9 and 10.11A from 2025 10-K.
• ·No arrangements or understandings pursuant to Ms. Gordon's election.

23-03-2026

On March 17, 2026, Jennifer Jarrett notified Arcus Biosciences, Inc. of her resignation as Chief Operating Officer, effective March 30, 2026, stating it was not due to any disagreement with the company's operations, policies, or practices. The company entered into a separation agreement under which Ms. Jarrett will provide periodic advisory services through June 30, 2026, in exchange for an extension of her post-termination vested option exercise period to 12 months.

• ·Separation agreement contains a standard release of claims.
• ·Full separation agreement to be filed with the next Form 10-Q.

23-03-2026

On March 20, 2026, Robert W. Dudley, a member of the Board of Directors of Freeport-McMoRan Inc., notified the Lead Independent Director and Chairman that he will not stand for re-election at the company's 2026 annual meeting of stockholders. Mr. Dudley will continue serving the remainder of his current term, which ends at that meeting. The decision was explicitly stated not to be due to any disagreement with the company.

23-03-2026

BitGo Holdings, Inc. disclosed the determination of Fiscal Year 2025 discretionary cash bonuses for its Named Executive Officers via an updated Summary Compensation Table, with total compensation ranging from $474,806 for CFO Edward Reginelli to $1,069,000 for Chief Revenue Officer Chen Fang. The Compensation Committee approved these on March 18, 2026, following the January 2026 IPO. Additionally, CFO Reginelli received a special $500,000 cash bonus and RSUs for 47,125 shares vesting over four years.

• ·All Other Compensation includes 401(k) matching: $14,000 for Reginelli and Fang, $13,309 for Mettler, $8,667 for Horowitz.
• ·RSU grant to CFO effective March 28, 2026, vests 25% after one year, then monthly over three years.
• ·No stock or option awards recognized in table for most NEOs except Mettler's options.

23-03-2026

On March 19, 2026, Virtuix Holdings Inc. (VTIX) appointed Cameron Slayter as Chief Product Officer, effective immediately, promoting him from Creative Director with an annual base salary of $175,000. The Board also changed Lauren Premo’s title to Chief Marketing Officer from Head of Marketing, with no change to her compensation. These internal promotions highlight continuity in leadership with no reported family relationships or material transactions involving the appointees.

• ·Cameron Slayter, age 33, has been with the company since 2014, leading game development and UI/UX design.
• ·No family relationships between appointees and any director or executive officer.
• ·No transactions requiring disclosure under Item 404(a) of Regulation S-K.

23-03-2026

Mesa Laboratories, Inc. announced the departure of Gary Owens as President and Chief Executive Officer, effective on or about April 13, 2026, following a Retention and Transition Agreement signed on March 20, 2026, under which he will remain in a non-executive capacity until the Separation Date of June 22, 2026. Owens also resigned from the Board of Directors on March 20, 2026, with no disagreements on company matters. Upon separation, he is entitled to severance pay, benefits for a 'without cause' termination, and a pro-rated portion of his June 15, 2025 performance stock unit award.

• ·Departure initially announced on March 9, 2026
• ·Resignation from Board effective March 20, 2026, not due to any disagreement
• ·PSU award vests at lower of target or actual performance for period ending June 15, 2025

23-03-2026

Stoneridge, Inc. (SRI) announced that Matt Horvath will resign as Chief Financial Officer and Treasurer effective March 31, 2026, as previously disclosed. The Board elected Robert J. Hartman, Jr., the Company's 27-year veteran and current Chief Accounting Officer, as Interim CFO and Treasurer effective the same date, while conducting a search for a permanent replacement. No family relationships or material conflicts exist with Mr. Hartman.

• ·Event reported on March 17, 2026; filing dated March 23, 2026.
• ·Mr. Hartman, age 59, has over 27 years at Stoneridge in accounting, finance, and internal audit.
• ·No arrangements or understandings with other persons for appointment; no interests under Item 404(a) of Regulation S-K.

23-03-2026

SiriusPoint Ltd reported the departure of Rob Gibbs, President & Chief Executive Officer of SiriusPoint International Insurance Corporation (publ), with his last day of employment on April 30, 2026. Under the March 17, 2026 Settlement Agreement, Gibbs will receive a total severance payment of 401,700 GBP in 12 monthly installments, continuation of private medical insurance through April 30, 2027, and life assurance through December 31, 2026 plus 3,000 GBP in lieu thereafter, but he is not entitled to a 2025 bonus. Gibbs remains bound by post-employment confidentiality, non-disparagement, non-compete, and non-solicitation obligations.

• ·Severance payment subject to income tax withholdings and National Insurance contributions.
• ·Outstanding equity awards treated per applicable agreements, as modified by Settlement Agreement.
• ·Settlement conditioned on execution and non-revocation of general release of claims.
• ·Announcement of departure via prior 8-K filed March 16, 2026.

23-03-2026

Robert N. Mackay, a director of Customers Bancorp, Inc. and its subsidiary Customers Bank since 2022, informed the company on March 20, 2026, that he intends to retire and not stand for reelection at the 2026 Annual Meeting of Shareholders to focus on his role as CEO of a global regulatory technology company. His retirement will become effective immediately following the meeting, and the decision is unrelated to any disagreements with the company's or bank's operations, policies, or practices.

• ·Mr. Mackay currently serves on the Company’s Directors Risk & Compliance Committee and Leadership Development & Compensation Committee.

23-03-2026

Hilary A. Schneider decided to depart from Sleep Number Corporation's Board of Directors upon the conclusion of the 2026 Annual Meeting of Shareholders due to new board service limitations from her recent appointment as Chief Executive Officer of SimpliSafe. The departure is not the result of any disagreement with the Company on operations, policies, or practices. The Company expressed thanks for her leadership and contributions.

• ·Event date: March 17, 2026
• ·Filing date: March 23, 2026

23-03-2026

Element Solutions Inc announced that Sir Martin E. Franklin, Executive Chairman of the Board, plans to step down and will not seek re-election at the 2026 Annual Meeting of Stockholders. Ian G.H. Ashken, a founding Board director since 2013 and Chair of the Nominating and Policies Committee, has been appointed Non-Executive Chairman effective at the Annual Meeting. Franklin will remain a substantial shareholder and continue as a counselor to CEO Ben Gliklich.

• ·Announcement dated March 23, 2026
• ·Ashken has been a founding director since 2013
• ·Franklin has partnered with CEO Gliklich for more than 12 years

23-03-2026

Dominari Holdings Inc. amended the employment agreements of CEO Anthony Hayes and President Kyle Wool on March 20, 2026 (effective immediately and retroactive to January 1, 2026), replacing annual bonus provisions with performance-based quarterly bonuses and a Net Revenue Bonus equal to 15% of net investment banking fees and alternate revenues from Dominari Securities LLC and other opportunities. In exchange, the Company issued 3,000,000 shares of common stock to each executive, as approved by shareholders on March 4, 2026. No other terms of the agreements were changed.

• ·Amendments replace Section 4(b) of original employment agreements dated June 28, 2022 (Hayes) and October 12, 2022 (Wool), most recently amended June 24, 2025
• ·Shares issued pursuant to registration statement on Form S-8
• ·Quarterly bonuses determined by Compensation Committee based on corporate performance and shareholder value creation

23-03-2026

On March 18, 2026, Intelligent Bio Solutions Inc. granted time-vesting restricted stock awards of 9,150 shares each to CEO Harry Simeonidis and CFO Spiro Sakiris (vesting after 48 months), plus performance-vesting awards of 21,350 shares each tied to clinical, regulatory, and commercial milestones; non-employee directors received an aggregate 20,000 time-vesting shares (vesting after 12 months), and non-executive employees received 10,500 time-vesting and 24,500 performance-vesting shares. As of March 23, 2026, the company had 2,001,173 shares of common stock outstanding following these grants and warrant exercises. The company also filed a 2026 ATM Supplement enabling up to $3.97M in additional common stock sales under its existing ATM Agreement.

• ·Performance-vesting shares subject to milestones: 30% upon clinical trial achievement (post-1 year), 40% upon FDA regulatory submission (post-1 year), 30% upon commercial supply/sales milestone (post-1 year); unachieved portions forfeit after 10 years.
• ·Awards include dividend rights on unvested shares (paid upon vesting) and are subject to clawback policy.
• ·ATM Agreement originally dated September 18, 2024; Registration Statement effective September 10, 2025 (File No. 333-286489).

23-03-2026

Crawford & Company appointed W. Bruce Swain Jr. as permanent President & CEO effective March 23, 2026, succeeding his interim role since January 1, 2026, due to his 30+ years of experience including 19 years as CFO. Jesse Crawford Sr., a board member since 1986, announced he will not stand for reelection at the May 14, 2026 Annual Shareholder Meeting and will transition to honorary board member, honoring his 40 years of service. The board expressed full confidence in Swain's leadership to advance the company's strategy.

• ·Swain served 19 years as CFO.
• ·Crawford family leadership spans generations, with Jesse Crawford Sr. as second generation.
• ·Company headquartered at 5335 Triangle Parkway NW, Peachtree Corners, GA 30092.

23-03-2026

Skillz Inc. extended CFO Gaetano Franceschi's departure date from March 31, 2026, to the earlier of October 1, 2026, or a mutually agreed date following the appointment of a permanent successor. Mr. Franceschi will continue receiving compensation per prior agreements and is eligible for a $300,000 retention payment (subject to service through October 1) plus a discretionary bonus up to $300,000 based on performance and transition success. The company is actively searching for a permanent CFO successor.

• ·Side Letter Amendment approved by Board and Compensation Committee on March 19, 2026.
• ·References prior Transition and Separation Agreement dated December 17, 2025, and Side Letter from December 30, 2025.
• ·Company address: 6625 Badura Avenue, Las Vegas, Nevada 89118.

23-03-2026

On March 19, 2026, the Board of Directors of Newsmax Inc. appointed David Evans as a member to fill an existing vacancy, effective immediately, and also to the Audit Committee alongside Rene Alexander Acosta and Paula J. Dobriansky. The Board determined Mr. Evans to be independent under New York Stock Exchange rules, with compensation per the Director Compensation Policy and no related arrangements or material transactions disclosed. A press release announcing the appointment was issued on March 23, 2026.

• ·Mr. Evans executed the Company’s standard form of indemnification agreement for directors (previously filed as Exhibit 6.7 to Form 1-A on February 7, 2025).
• ·Information in Item 7.01 and Exhibit 99.1 is furnished, not filed, under Regulation FD.

23-03-2026

Oil States International, Inc. announced the retirement of President and CEO Cindy Taylor effective May 1, 2026, with Executive Vice President, CFO, and Treasurer Lloyd Hajdik succeeding her as President and CEO and joining the Board. Matthew E. Autenrieth will be appointed as the new Executive Vice President, CFO, and Treasurer effective the same date. Taylor will remain in a consulting role through October 31, 2026, supporting a seamless transition amid the company's strong position with a clean balance sheet, little to no debt, and record backlog.

• ·Cindy Taylor has over 25 years of service to Oil States, including 19 years as CEO.
• ·Lloyd Hajdik joined Oil States in December 2013; served as Senior VP, CFO from Dec 2013 to May 2016, then EVP, CFO since May 2016.
• ·Matthew E. Autenrieth joined Oil States in December 2007.
• ·Oil States provides manufactured products and services to energy, military, and industrial sectors.

23-03-2026

On March 20, 2026, CBRE Group, Inc.'s board adopted the Second Amended and Restated Change in Control and Severance Plan for Senior Management, effective immediately but with adverse modifications delayed until March 20, 2027 for existing participants. The plan reduces cash severance multiples outside the Change in Control Protection Period for Tier I (CEO) from 2.0x to 1.5x, Tier II (executive officers) from 1.5x to 1.25x, and Tier III from 1.0x to 0.75x, while equity vesting multiples are similarly lowered (e.g., Tier I from 24 to 18 months). Changes include pro-rating bonuses at 100% target, modified Good Reason definition requiring over 15% equity grant cut, added non-compete, and faster settlement of certain awards.

• ·Pro-rated annual bonus limited to 100% of target, based on full months of active service excluding garden leave.
• ·Time-based equity awards: partial vesting based on full months worked plus Equity Multiple; immediate settlement for accelerated RSUs (exceptions for pre-2026 retirement-eligible grants).
• ·Performance-based awards: pro-rata shares remain eligible to vest on original schedule based on full months plus Equity Multiple.
• ·Restrictive covenants period aligned to multiples: e.g., Tier I outside CIC now 18 months (was implied longer); non-compete added.

23-03-2026

Globus Medical, Inc. (NYSE:GMED) announced that Director John A. DeFord, Ph.D., has stepped down from the Board effective immediately and will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026. The company thanked him for his contributions, especially during the merger with NuVasive and service on the Nominating and Governance Committee. Chairman David C. Paul expressed appreciation for his insights while wishing him success ahead.

• ·Filing date: March 23, 2026

23-03-2026

On March 23, 2026, Adam Peterson resigned from Nelnet, Inc.'s Board of Directors effective immediately for business and personal reasons, not due to any disagreement with the company's operations, policies, or practices. The Board and management expressed appreciation for his dedicated service and significant contributions during his tenure.

• ·Resignation notified on March 23, 2026, and effective immediately.
• ·Company headquartered at 121 South 13th Street, Suite 100, Lincoln, Nebraska 68508.

23-03-2026

On March 20, 2026, Hans Thomas resigned from the Board of Directors of CEA Industries Inc., effective immediately, with no disagreement cited regarding the company's operations, policies, or practices. The Board, which consists of a majority of independent directors, plans to fill the resulting vacancy through its ongoing search process. This is a routine governance change with no associated financial impact disclosed.

23-03-2026

Aurinia Pharmaceuticals Inc. (AUPH) announced a management transition where Kevin Tang, Chair of the Board, succeeds Peter Greenleaf as CEO after his 7-year tenure, with Greenleaf continuing as a consultant. The company appointed Ryan Cole as COO, Michael Hearne as CFO, and Thomas Wei as CSO, while Stew Kroll and Stephen Robertson continue as Chief Development Officer and General Counsel. Aurinia highlighted its strong position, with LUPKYNIS emerging as a standard therapy for lupus nephritis and aritinercept advancing in clinical studies.

• ·LUPKYNIS FDA-approved in January 2021 as the first oral therapy for adult patients with active lupus nephritis
• ·Aritinercept is a dual inhibitor of BAFF and APRIL for autoimmune diseases

23-03-2026

On March 19, 2026, Jeff Epstein informed Okta, Inc. that he would resign from the Board of Directors, effective at the Company's 2026 annual meeting of stockholders planned for June 18, 2026. The departure is not the result of any disagreement with the Company. The Board expressed appreciation for Mr. Epstein's service and contributions.

• ·Filing submitted on March 23, 2026, pursuant to Items 5.02 and 9.01 of Form 8-K.

23-03-2026

Ridgepost Capital announced the retirement of Mark Hood as Executive Vice President and Chief Administration Officer, effective May 31, 2026, with him continuing as a strategic advisor to ensure a seamless transition. CEO Luke Sarsfield commended Hood's contributions since prior to the October 2021 IPO. The company, with over $43B in assets under management as of December 31, 2025, has initiated a search for a successor.

• ·Announcement date: March 23, 2026
• ·Retirement effective: May 31, 2026
• ·IPO reference: October 2021
• ·Investor contact: info@ridgepostcapital.com
• ·Media contacts: Josh Clarkson, Taylor Donahue (pro-ridgepost@prosek.com)

23-03-2026

Gladstone Capital Corporation (Nasdaq: GLAD) announced a strategic succession plan effective March 23, 2026, with founder David Gladstone stepping down as CEO but remaining Chairman, Robert Marcotte succeeding as CEO, John Sateri appointed CIO, Andrew Ahlberg as EVP immediately, and Michael McQuigg as President effective October 1, 2026. This ensures leadership continuity after 25 years, during which the company completed 715 loans and investments across 294 companies, totaling $3.3B in invested capital through December 31, 2025. The changes separate Chairman and CEO roles to enhance corporate governance.

• ·Company founded in 2001 as one of the first BDCs focused on lending to lower middle market businesses.
• ·One of the first BDCs to provide second lien loans.

23-03-2026

On March 20, 2026, Gladstone Land Corporation appointed John Sateri, age 58, as Chief Investment Officer (CIO), effective immediately, following his prior role as Executive Vice President of Investments since September 2021. Mr. Sateri, with the Gladstone Companies since April 2007, was simultaneously appointed CIO of Gladstone Capital Corporation, Gladstone Commercial Corporation, Gladstone Investment Corporation, and Gladstone Management Corporation (the Adviser). The Company has no direct employees, with all officers employed by the Adviser or Gladstone Administration, LLC.

• ·Mr. Sateri holds a bachelor’s degree in Business Administration from The University of Hawaii at Manoa and a master’s degree in Real Estate Development from the University of Maryland at College Park.
• ·Mr. Sateri has served as President of Gladstone Alternative Income Fund (GALT) since its inception in June 2024.
• ·No family relationships or arrangements with respect to the appointment; no reportable transactions under Item 404(a) of Regulation S-K.

23-03-2026

Gladstone Commercial Corporation (Nasdaq: GOOD) announced a strategic succession plan effective immediately on March 23, 2026, with founder David Gladstone stepping down as CEO to remain Chairman of the Board and involved in key roles, while Arthur 'Buzz' Cooper was appointed CEO and President. Additional promotions include John Sateri as Chief Investment Officer, Gary Gerson as Executive Vice President (in addition to CFO and Assistant Treasurer), and Ryan Carter as Executive Vice President. The changes emphasize management depth and separate Chairman/CEO roles for better governance, highlighting the REIT's growth to over 150 single-tenant net leased industrial properties as of December 31, 2025.

• ·David Gladstone founded the company in 2003 and led it from IPO to current status.
• ·Company's 10-K for fiscal year ended December 31, 2025, filed with SEC on February 18, 2026.
• ·Gladstone family of funds celebrating 25th year in business.

23-03-2026

Gladstone Investment Corporation announced a strategic succession plan effective March 23, 2026, with founder David Gladstone stepping down as CEO but remaining Chairman; David Dullum succeeding as CEO, John Sateri appointed Chief Investment Officer, and Erika Highland and Christopher Lee elevated to Executive Vice Presidents, with Highland to become President on October 1, 2026. The changes separate Chairman and CEO roles, highlighting management depth and the company's growth from its 2005 IPO to over $1.2B in total assets. Leadership expressed confidence in continued success amid the Gladstone funds' 25th anniversary.

• ·David Gladstone founded the company in 2005 and has led it for 21 years.
• ·Erika Highland has over 20 years at Gladstone.
• ·10-K for fiscal year ended March 31, 2025 filed with SEC on May 13, 2025.

23-03-2026

On March 17, 2026, Jeff Knight notified Crinetics Pharmaceuticals, Inc. of his resignation as Chief Development and Operating Officer, effective on or about April 10, 2026, to pursue another opportunity. The resignation is not related to any disagreement with the company's operations, policies, or practices. All of Mr. Knight's managerial responsibilities and direct reports will be reassigned to other members of the executive leadership team.

• ·Filing submitted on March 23, 2026
• ·Company headquartered at 6055 Lusk Boulevard, San Diego, California 92121

23-03-2026

Damora Therapeutics appointed biotechnology executive Jennifer Jarrett as President and Chief Executive Officer effective March 30, 2026, and added industry veterans Cameron Turtle and Mike Landsittel to its Board of Directors, with Peter Harwin named Chairman. The company acknowledged departing directors Dr. Carl Goldfischer, Dr. Jayson Dallas, and Amit Munshi for their contributions to the Damora-Galecto transaction. Damora is positioned to advance its lead program DMR-001 and other pipeline assets for mutCALR-driven myeloproliferative neoplasms into clinical development in 2026.

• ·Jennifer Jarrett's prior roles include COO and CFO at Arcus Biosciences, VP Corporate Development at Uber, and CFO at Medivation.
• ·Mike Landsittel led Blueprint Medicines' transition to commercialization and raised $4B in capital prior to Sanofi acquisition.
• ·Damora programs targeted for clinical development entry in 2026.

23-03-2026

TTEC Holdings announced the appointment of Chris Brown as president of TTEC Digital effective immediately, succeeding Dave Seybold who will depart as CEO on April 30, 2026, after ensuring a seamless transition. Brown, who joined TTEC in 2015 and previously served as Chief of Staff to Chairman and CEO Ken Tuchman, will lead TTEC Digital's global strategy, P&L, and operations. The company highlighted Brown's experience in technology partnerships and Seybold's contributions over the past three years in establishing the TTEC Digital brand and AI vision.

• ·TTEC founded in 1982 and operates on six continents.
• ·Brown joined TTEC in 2015; Seybold led TTEC Digital for past three years.
• ·Brown holds MBA from University of Chicago Booth School of Business and serves on Percepta Board.

23-03-2026

The Federal Home Loan Bank of Indianapolis announced the departure of Deron J. Streitenberger, Executive Vice President – Chief Business Operations Officer, effective March 23, 2026, due to the elimination of his position as part of an organizational realignment. The filing was signed by Brendan W. McGrath, President - Chief Executive Officer. No replacement or further details on the realignment were provided.

• ·Filing Type: 8-K, Item 5.02 (Departure of Directors or Certain Officers)
• ·Commission File Number: 000-51404
• ·IRS Employer Identification No.: 35-6001443
• ·Principal Executive Offices: 8250 Woodfield Crossing Blvd., Indianapolis IN 46240

23-03-2026

Solo Brands, Inc. rebalanced its Board of Directors on March 19-21, 2026, by having director Peter Laurinaitis resign from Class III and be immediately re-elected to Class II, resulting in three Class I directors, two Class II directors, and two Class III directors, with his service deemed uninterrupted. The Company also amended the consent of its former auditor, Ernst & Young LLP, filed with its Form 10-K for the fiscal year ended December 31, 2025, solely to update the consent date without altering any financial results or disclosures.

• ·Mr. Laurinaitis continues service on the Audit Committee uninterrupted.
• ·Amended consent filed as Exhibit 23.1 supersedes prior Exhibit 23.2 in Form 10-K.
• ·Form 10-K covers fiscal year ended December 31, 2025, filed March 23, 2026.